GENTAUR Belgium BVBA BE0473327336 Voortstraat 49, 1910 Kampenhout BELGIUM Tel 0032 16 58 90 45
GENTAUR U.S.A Genprice Inc,Logistics 547 Yurok Circle, SanJose, CA 95123
Tel (408) 780-0908, Fax (408) 780-0908, [email protected]

Did you know ? If you order before Friday 14h we deliver 90PCT of the the time next Tuesday, Gentaur another in time delivery

Major prion protein (PrP) (CD antigen CD230)

 PRIO_SHEEP              Reviewed;         256 AA.
P23907; Q5ECG0; Q6V638; Q6V654; Q712W2; Q712W3; Q7JGT4;
01-NOV-1991, integrated into UniProtKB/Swiss-Prot.
01-NOV-1991, sequence version 1.
13-FEB-2019, entry version 147.
RecName: Full=Major prion protein;
Short=PrP;
AltName: CD_antigen=CD230;
Flags: Precursor;
Name=PRNP; Synonyms=PRP, SIP;
Ovis aries (Sheep).
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
Mammalia; Eutheria; Laurasiatheria; Cetartiodactyla; Ruminantia;
Pecora; Bovidae; Caprinae; Ovis.
NCBI_TaxID=9940;
[1]
NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT GLN-171.
STRAIN=Suffolk; TISSUE=Spleen;
PubMed=1969635; DOI=10.1073/pnas.87.7.2476;
Goldmann W., Hunter N., Foster J.D., Salbaum J.M., Beyreuther K.,
Hope J.;
"Two alleles of a neural protein gene linked to scrapie in sheep.";
Proc. Natl. Acad. Sci. U.S.A. 87:2476-2480(1990).
[2]
NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT GLN-171.
STRAIN=Suffolk; TISSUE=Brain;
PubMed=7926780; DOI=10.1101/gad.8.8.959;
Westaway D., Zuliani V., Cooper C.M., da Costa M., Neuman S.,
Jenny A.L., Detwiler L., Prusiner S.B.;
"Homozygosity for prion protein alleles encoding glutamine-171 renders
sheep susceptible to natural scrapie.";
Genes Dev. 8:959-969(1994).
[3]
NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT GLN-171.
TISSUE=Brain;
PubMed=9799790;
Lee I.Y., Westaway D., Smit A.F.A., Wang K., Seto J., Chen L.,
Acharya C., Ankener M., Baskin D., Cooper C., Yao H., Prusiner S.B.,
Hood L.E.;
"Complete genomic sequence and analysis of the prion protein gene
region from three mammalian species.";
Genome Res. 8:1022-1037(1998).
[4]
NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT GLN-171.
PubMed=10466827;
Goldmann W., O'Neill G., Cheung F., Charleson F., Ford P., Hunter N.;
"PrP (prion) gene expression in sheep may be modulated by alternative
polyadenylation of its messenger RNA.";
J. Gen. Virol. 80:2275-2283(1999).
[5]
NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT GLN-171.
PubMed=14970684; DOI=10.1159/000075730;
Seabury C.M., Derr J.N.;
"Identification of a novel ovine PrP polymorphism and scrapie-
resistant genotypes for St. Croix White and a related composite
breed.";
Cytogenet. Genome Res. 102:85-88(2003).
[6]
NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS PHE-141 AND GLN-171.
PubMed=14769911; DOI=10.1099/vir.0.19520-0;
Billinis C., Psychas V., Leontides L., Spyrou V., Argyroudis S.,
Vlemmas I., Leontides S., Sklaviadis T., Papadopoulos O.;
"Prion protein gene polymorphisms in healthy and scrapie affected
sheep in Greece.";
J. Gen. Virol. 85:547-554(2004).
[7]
NUCLEOTIDE SEQUENCE [GENOMIC DNA].
TISSUE=Liver;
Inoue S., Watanabe A., Horiuchi M., Ishiguro N., Shinagawa M.;
Submitted (SEP-1994) to the EMBL/GenBank/DDBJ databases.
[8]
NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS PHE-141; GLN-171 AND
GLN-211.
Bossers A.;
"PrP allelic variants associated with natural scrapie.";
Submitted (AUG-1997) to the EMBL/GenBank/DDBJ databases.
[9]
NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT GLN-171.
Heaton M.P., Leymaster K.A., Clawson M.L., Laegreid W.W.;
"A set of genotyping controls for 15 haplotype combinations of ovine
PRNP codons 136, 154, and 171.";
Submitted (JAN-2005) to the EMBL/GenBank/DDBJ databases.
[10]
IDENTIFICATION IN COMPLEX WITH CES5A; CLU; BPI; MANBA AND GLB1.
TISSUE=Epididymis;
PubMed=16029166; DOI=10.1042/BJ20050459;
Ecroyd H., Belghazi M., Dacheux J.-L., Gatti J.-L.;
"The epididymal soluble prion protein forms a high-molecular-mass
complex in association with hydrophobic proteins.";
Biochem. J. 392:211-219(2005).
[11]
X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) OF 128-233.
PubMed=15037077; DOI=10.1016/j.jmb.2003.12.059;
Haire L.F., Whyte S.M., Vasisht N., Gill A.C., Verma C., Dodson E.J.,
Dodson G.G., Bayley P.M.;
"The crystal structure of the globular domain of sheep prion
protein.";
J. Mol. Biol. 336:1175-1183(2004).
[12]
X-RAY CRYSTALLOGRAPHY (2.56 ANGSTROMS) OF 115-234 IN COMPLEX WITH
ANTIBODY.
PubMed=15240887; DOI=10.1073/pnas.0400014101;
Eghiaian F., Grosclaude J., Lesceu S., Debey P., Doublet B.,
Treguer E., Rezaei H., Knossow M.;
"Insight into the PrPC-->PrPSc conversion from the structures of
antibody-bound ovine prion scrapie-susceptibility variants.";
Proc. Natl. Acad. Sci. U.S.A. 101:10254-10259(2004).
[13]
STRUCTURE BY NMR OF 124-234.
PubMed=15647367; DOI=10.1073/pnas.0408937102;
Lysek D.A., Schorn C., Nivon L.G., Esteve-Moya V., Christen B.,
Calzolai L., von Schroetter C., Fiorito F., Herrmann T., Guentert P.,
Wuethrich K.;
"Prion protein NMR structures of cats, dogs, pigs, and sheep.";
Proc. Natl. Acad. Sci. U.S.A. 102:640-645(2005).
[14]
STRUCTURE BY NMR OF 167-234, SUBUNIT, AND DOMAIN.
PubMed=20375014; DOI=10.1074/jbc.M110.111815;
Adrover M., Pauwels K., Prigent S., de Chiara C., Xu Z., Chapuis C.,
Pastore A., Rezaei H.;
"Prion fibrillization is mediated by a native structural element that
comprises helices H2 and H3.";
J. Biol. Chem. 285:21004-21012(2010).
[15]
VARIANTS SCRAPIE VAL-136; HIS-154 AND GLN-171, AND POLYMORPHISM.
PubMed=1681027; DOI=10.1099/0022-1317-72-10-2411;
Goldmann W., Hunter N., Benson G., Foster J.D., Hope J.;
"Different scrapie-associated fibril proteins (PrP) are encoded by
lines of sheep selected for different alleles of the Sip gene.";
J. Gen. Virol. 72:2411-2417(1991).
[16]
VARIANTS SCRAPIE THR-112; VAL-136 AND HIS-154.
PubMed=8094373; DOI=10.1006/geno.1993.1006;
Laplanche J.-L., Chatelain J., Westaway D., Thomas S., Dussaucy M.,
Brugere-Picoux J., Launay J.-M.;
"PrP polymorphisms associated with natural scrapie discovered by
denaturing gradient gel electrophoresis.";
Genomics 15:30-37(1993).
[17]
VARIANTS SCRAPIE VAL-136 AND HIS-171, AND VARIANT HIS-154.
PubMed=7897344; DOI=10.1099/0022-1317-76-3-509;
Belt P.B.G.M., Muileman I.H., Schreuder B.E.C., Bos-De Ruijter J.,
Gielkens A.L.J., Smits M.A.;
"Identification of five allelic variants of the sheep PrP gene and
their association with natural scrapie.";
J. Gen. Virol. 76:509-517(1995).
[18]
VARIANTS THR-137; PHE-141 AND GLN-211.
PubMed=8887505; DOI=10.1099/0022-1317-77-10-2669;
Bossers A., Schreuder B.E.C., Muileman I.H., Belt P.B.G.M.,
Smits M.A.;
"PrP genotype contributes to determining survival times of sheep with
natural scrapie.";
J. Gen. Virol. 77:2669-2673(1996).
-!- FUNCTION: Its primary physiological function is unclear. Has
cytoprotective activity against internal or environmental
stresses. May play a role in neuronal development and synaptic
plasticity. May be required for neuronal myelin sheath
maintenance. May play a role in iron uptake and iron homeostasis.
Soluble oligomers are toxic to cultured neuroblastoma cells and
induce apoptosis (in vitro). Association with GPC1 (via its
heparan sulfate chains) targets PRNP to lipid rafts. Also provides
Cu(2+) or ZN(2+) for the ascorbate-mediated GPC1 deaminase
degradation of its heparan sulfate side chains (By similarity).
{ECO:0000250|UniProtKB:P04156, ECO:0000250|UniProtKB:P04925}.
-!- SUBUNIT: Monomer and homodimer. Has a tendency to aggregate into
amyloid fibrils containing a cross-beta spine, formed by a steric
zipper of superposed beta-strands. Soluble oligomers may represent
an intermediate stage on the path to fibril formation. Copper
binding may promote oligomerization. Interacts with GRB2, APP,
ERI3/PRNPIP and SYN1. Mislocalized cytosolically exposed PrP
interacts with MGRN1; this interaction alters MGRN1 subcellular
location and causes lysosomal enlargement. Interacts with
KIAA1191. {ECO:0000250|UniProtKB:P04156,
ECO:0000250|UniProtKB:P04925}.
-!- INTERACTION:
Self; NbExp=3; IntAct=EBI-7670302, EBI-7670302;
P04156:PRNP (xeno); NbExp=3; IntAct=EBI-7670302, EBI-977302;
-!- SUBCELLULAR LOCATION: Cell membrane
{ECO:0000250|UniProtKB:P04156}; Lipid-anchor, GPI-anchor
{ECO:0000250|UniProtKB:P04156}. Golgi apparatus
{ECO:0000250|UniProtKB:P04925}. Note=Targeted to lipid rafts via
association with the heparan sulfate chains of GPC1. Colocates, in
the presence of Cu(2+), to vesicles in para- and perinuclear
regions, where both proteins undergo internalization. Heparin
displaces PRNP from lipid rafts and promotes endocytosis.
{ECO:0000250|UniProtKB:P04156}.
-!- DOMAIN: The normal, monomeric form has a mainly alpha-helical
structure. The disease-associated, protease-resistant form forms
amyloid fibrils containing a cross-beta spine, formed by a steric
zipper of superposed beta-strands. Disease mutations may favor
intermolecular contacts via short beta strands, and may thereby
trigger oligomerization. {ECO:0000250|UniProtKB:P04156}.
-!- DOMAIN: Contains an N-terminal region composed of octamer repeats.
At low copper concentrations, the sidechains of His residues from
three or four repeats contribute to the binding of a single copper
ion. Alternatively, a copper ion can be bound by interaction with
the sidechain and backbone amide nitrogen of a single His residue.
The observed copper binding stoichiometry suggests that two repeat
regions cooperate to stabilize the binding of a single copper ion.
At higher copper concentrations, each octamer can bind one copper
ion by interactions with the His sidechain and Gly backbone atoms.
A mixture of binding types may occur, especially in the case of
octamer repeat expansion. Copper binding may stabilize the
conformation of this region and may promote oligomerization.
{ECO:0000250|UniProtKB:P04156}.
-!- DISEASE: Note=Polymorphism at position 171 may be related to the
alleles of scrapie incubation-control (SIC) gene in this species.
{ECO:0000269|PubMed:1681027}.
-!- DISEASE: Note=Found in high quantity in the brain of humans and
animals infected with degenerative neurological diseases such as
kuru, Creutzfeldt-Jakob disease (CJD), Gerstmann-Straussler
syndrome (GSS), scrapie, bovine spongiform encephalopathy (BSE),
transmissible mink encephalopathy (TME), etc. {ECO:0000305}.
-!- DISEASE: Note=Scrapie is a transmissible neurodegenerative
disorder of sheep and goats. Most sheep that contract the disease
naturally die between 24 and 50 months of age. The incubation
period in sheep depends on the strain(s) of the infecting
pathogen, sheep age at exposure, and the sheep genotype. The
survival time is mainly determined by a single genetic locus, SIP,
which has two alleles, susceptible (sa) and resistant (pa). Short
incubation period is conferred by the partially dominant sa
allele. Scrapie can be spread between flockmates, or it can be
transmitted from an infected ewe to its lamb.
{ECO:0000269|PubMed:1681027, ECO:0000269|PubMed:7897344,
ECO:0000269|PubMed:8094373}.
-!- MISCELLANEOUS: This protein is produced by a bicistronic gene
which also produces the major prion protein/PRNP from an
overlapping reading frame.
-!- MISCELLANEOUS: The alternative prion protein/AltPrP (AC F7VJQ3)
and PRNP have no apparent direct functional relation since a
mutation that removes the start codon of the AltPrP has no
apparent effect on the biology of PRNP (By similarity). In mouse
and hamster, the alternative initiation AUG codon is absent and is
replaced by a GUG codon. {ECO:0000250}.
-!- SIMILARITY: Belongs to the prion family. {ECO:0000305}.
-----------------------------------------------------------------------
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
-----------------------------------------------------------------------
EMBL; M31313; AAB97765.1; -; Genomic_DNA.
EMBL; X79912; CAA56283.1; -; Genomic_DNA.
EMBL; U67922; AAC78726.1; -; Genomic_DNA.
EMBL; AJ223072; CAA11073.1; -; Genomic_DNA.
EMBL; AY350241; AAR14214.1; -; Genomic_DNA.
EMBL; AY350242; AAR14215.1; -; Genomic_DNA.
EMBL; AY350243; AAR14216.1; -; Genomic_DNA.
EMBL; AY350245; AAR14218.1; -; Genomic_DNA.
EMBL; AY350246; AAR14219.1; -; Genomic_DNA.
EMBL; AY350248; AAR14221.1; -; Genomic_DNA.
EMBL; AY350249; AAR14222.1; -; Genomic_DNA.
EMBL; AY350250; AAR14223.1; -; Genomic_DNA.
EMBL; AY350254; AAR14227.1; -; Genomic_DNA.
EMBL; AY350256; AAR14229.1; -; Genomic_DNA.
EMBL; AY350257; AAR14230.1; -; Genomic_DNA.
EMBL; AY350261; AAR14234.1; -; Genomic_DNA.
EMBL; AY350264; AAR14237.1; -; Genomic_DNA.
EMBL; AY350267; AAR14240.1; -; Genomic_DNA.
EMBL; AY350268; AAR14241.1; -; Genomic_DNA.
EMBL; AY350271; AAR14244.1; -; Genomic_DNA.
EMBL; AY350272; AAR14245.1; -; Genomic_DNA.
EMBL; AY350273; AAR14246.1; -; Genomic_DNA.
EMBL; AY350275; AAR14248.1; -; Genomic_DNA.
EMBL; AJ567984; CAE00186.1; -; Genomic_DNA.
EMBL; AJ567985; CAE00187.1; -; Genomic_DNA.
EMBL; AJ567986; CAE00188.2; -; Genomic_DNA.
EMBL; D38179; BAA07376.1; -; Genomic_DNA.
EMBL; AJ000680; CAA04235.1; -; Genomic_DNA.
EMBL; AJ000681; CAA04236.1; -; Genomic_DNA.
EMBL; AJ000736; CAA04274.1; -; Genomic_DNA.
EMBL; AJ000739; CAA04277.1; -; Genomic_DNA.
EMBL; AY907689; AAW88336.1; -; Genomic_DNA.
EMBL; AY907690; AAW88337.1; -; Genomic_DNA.
EMBL; AY907691; AAW88338.1; -; Genomic_DNA.
RefSeq; NP_001009481.1; NM_001009481.1.
RefSeq; XP_012043480.1; XM_012188090.2.
UniGene; Oar.765; -.
PDB; 1G04; NMR; -; A=145-169.
PDB; 1M25; NMR; -; A=145-169.
PDB; 1S4T; NMR; -; A=138-158.
PDB; 1TPX; X-ray; 2.56 A; A=114-234.
PDB; 1TQB; X-ray; 2.55 A; A=127-228.
PDB; 1TQC; X-ray; 2.80 A; A=127-228.
PDB; 1UW3; X-ray; 2.04 A; A=128-233.
PDB; 1XYU; NMR; -; A=124-234.
PDB; 1Y2S; NMR; -; A=124-234.
PDB; 2KTM; NMR; -; A=172-234.
PDB; 2MV8; NMR; -; A=103-234.
PDB; 2MV9; NMR; -; A=103-234.
PDB; 2N53; NMR; -; A=103-234.
PDB; 2RMV; NMR; -; A=145-169.
PDB; 2RMW; NMR; -; A=145-169.
PDBsum; 1G04; -.
PDBsum; 1M25; -.
PDBsum; 1S4T; -.
PDBsum; 1TPX; -.
PDBsum; 1TQB; -.
PDBsum; 1TQC; -.
PDBsum; 1UW3; -.
PDBsum; 1XYU; -.
PDBsum; 1Y2S; -.
PDBsum; 2KTM; -.
PDBsum; 2MV8; -.
PDBsum; 2MV9; -.
PDBsum; 2N53; -.
PDBsum; 2RMV; -.
PDBsum; 2RMW; -.
ProteinModelPortal; P23907; -.
SMR; P23907; -.
DIP; DIP-60917N; -.
IntAct; P23907; 1.
MINT; P23907; -.
BindingDB; P23907; -.
ChEMBL; CHEMBL2406893; -.
TCDB; 1.C.48.1.1; the prion peptide (prp) family.
Ensembl; ENSOART00000005076; ENSOARP00000004991; ENSOARG00000004668.
GeneID; 493887; -.
KEGG; oas:493887; -.
CTD; 5621; -.
GeneTree; ENSGT00510000049083; -.
HOVERGEN; HBG008260; -.
KO; K05634; -.
OMA; HNPGYPH; -.
EvolutionaryTrace; P23907; -.
PRO; PR:P23907; -.
Proteomes; UP000002356; Chromosome 13.
ExpressionAtlas; P23907; baseline.
GO; GO:0031225; C:anchored component of membrane; IEA:UniProtKB-KW.
GO; GO:0009986; C:cell surface; IEA:Ensembl.
GO; GO:0005829; C:cytosol; IEA:Ensembl.
GO; GO:0030425; C:dendrite; IEA:Ensembl.
GO; GO:0005783; C:endoplasmic reticulum; IEA:Ensembl.
GO; GO:0005794; C:Golgi apparatus; IEA:UniProtKB-SubCell.
GO; GO:0016234; C:inclusion body; IEA:Ensembl.
GO; GO:0045121; C:membrane raft; IEA:Ensembl.
GO; GO:0031965; C:nuclear membrane; IEA:Ensembl.
GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
GO; GO:0001540; F:amyloid-beta binding; IEA:Ensembl.
GO; GO:0005507; F:copper ion binding; ISS:UniProtKB.
GO; GO:1903135; F:cupric ion binding; IEA:Ensembl.
GO; GO:1903136; F:cuprous ion binding; IEA:Ensembl.
GO; GO:0005539; F:glycosaminoglycan binding; IEA:Ensembl.
GO; GO:0042802; F:identical protein binding; IPI:IntAct.
GO; GO:0008017; F:microtubule binding; ISS:AgBase.
GO; GO:0002020; F:protease binding; IEA:Ensembl.
GO; GO:0044877; F:protein-containing complex binding; IEA:Ensembl.
GO; GO:0038023; F:signaling receptor activity; IEA:Ensembl.
GO; GO:0015631; F:tubulin binding; ISS:AgBase.
GO; GO:0031802; F:type 5 metabotropic glutamate receptor binding; IEA:Ensembl.
GO; GO:0032147; P:activation of protein kinase activity; IEA:Ensembl.
GO; GO:0035584; P:calcium-mediated signaling using intracellular calcium source; IEA:Ensembl.
GO; GO:1904646; P:cellular response to amyloid-beta; IEA:Ensembl.
GO; GO:0071280; P:cellular response to copper ion; IEA:Ensembl.
GO; GO:0035690; P:cellular response to drug; IEA:Ensembl.
GO; GO:0007611; P:learning or memory; IEA:Ensembl.
GO; GO:0090647; P:modulation of age-related behavioral decline; IEA:Ensembl.
GO; GO:0046007; P:negative regulation of activated T cell proliferation; IEA:Ensembl.
GO; GO:1902430; P:negative regulation of amyloid-beta formation; IEA:Ensembl.
GO; GO:0043066; P:negative regulation of apoptotic process; IEA:Ensembl.
GO; GO:0070885; P:negative regulation of calcineurin-NFAT signaling cascade; IEA:Ensembl.
GO; GO:1902951; P:negative regulation of dendritic spine maintenance; IEA:Ensembl.
GO; GO:0043433; P:negative regulation of DNA-binding transcription factor activity; IEA:Ensembl.
GO; GO:0032689; P:negative regulation of interferon-gamma production; IEA:Ensembl.
GO; GO:0032700; P:negative regulation of interleukin-17 production; IEA:Ensembl.
GO; GO:0032703; P:negative regulation of interleukin-2 production; IEA:Ensembl.
GO; GO:0001933; P:negative regulation of protein phosphorylation; IEA:Ensembl.
GO; GO:0050860; P:negative regulation of T cell receptor signaling pathway; IEA:Ensembl.
GO; GO:1990535; P:neuron projection maintenance; IEA:Ensembl.
GO; GO:0043525; P:positive regulation of neuron apoptotic process; IEA:Ensembl.
GO; GO:1903078; P:positive regulation of protein localization to plasma membrane; IEA:Ensembl.
GO; GO:0090314; P:positive regulation of protein targeting to membrane; IEA:Ensembl.
GO; GO:0061098; P:positive regulation of protein tyrosine kinase activity; IEA:Ensembl.
GO; GO:0031648; P:protein destabilization; IEA:Ensembl.
GO; GO:0051260; P:protein homooligomerization; IEA:Ensembl.
GO; GO:1905664; P:regulation of calcium ion import across plasma membrane; IEA:Ensembl.
GO; GO:1900449; P:regulation of glutamate receptor signaling pathway; IEA:Ensembl.
GO; GO:1902938; P:regulation of intracellular calcium activated chloride channel activity; IEA:Ensembl.
GO; GO:1901379; P:regulation of potassium ion transmembrane transport; IEA:Ensembl.
GO; GO:0006979; P:response to oxidative stress; IEA:Ensembl.
Gene3D; 1.10.790.10; -; 1.
InterPro; IPR000817; Prion.
InterPro; IPR036924; Prion/Doppel_b-ribbon_dom_sf.
InterPro; IPR022416; Prion/Doppel_prot_b-ribbon_dom.
InterPro; IPR025860; Prion_N_dom.
PANTHER; PTHR10502:SF134; PTHR10502:SF134; 1.
Pfam; PF00377; Prion; 1.
Pfam; PF11587; Prion_bPrPp; 1.
PRINTS; PR00341; PRION.
SMART; SM00157; PRP; 1.
SUPFAM; SSF54098; SSF54098; 1.
PROSITE; PS00291; PRION_1; 1.
PROSITE; PS00706; PRION_2; 1.
1: Evidence at protein level;
3D-structure; Amyloid; Cell membrane; Complete proteome; Copper;
Disease mutation; Disulfide bond; Glycoprotein; Golgi apparatus;
GPI-anchor; Lipoprotein; Membrane; Metal-binding; Polymorphism; Prion;
Reference proteome; Repeat; Signal; Zinc.
SIGNAL 1 24
CHAIN 25 233 Major prion protein.
/FTId=PRO_0000025727.
PROPEP 234 256 Removed in mature form. {ECO:0000255}.
/FTId=PRO_0000025728.
REPEAT 54 62 1.
REPEAT 63 70 2.
REPEAT 71 78 3.
REPEAT 79 86 4.
REPEAT 87 95 5.
REGION 25 233 Interaction with GRB2, ERI3 and SYN1.
{ECO:0000250|UniProtKB:P04925}.
REGION 54 95 5 X 8 AA tandem repeats of P-H-G-G-G-W-G-
Q.
METAL 64 64 Copper or zinc 1.
{ECO:0000250|UniProtKB:P04156}.
METAL 65 65 Copper or zinc 1; via amide nitrogen.
{ECO:0000250|UniProtKB:P04156}.
METAL 66 66 Copper or zinc 1; via amide nitrogen and
carbonyl oxygen.
{ECO:0000250|UniProtKB:P04156}.
METAL 72 72 Copper or zinc 2.
{ECO:0000250|UniProtKB:P04156}.
METAL 73 73 Copper or zinc 2; via amide nitrogen.
{ECO:0000250|UniProtKB:P04156}.
METAL 74 74 Copper or zinc 2; via amide nitrogen and
carbonyl oxygen.
{ECO:0000250|UniProtKB:P04156}.
METAL 80 80 Copper or zinc 3.
{ECO:0000250|UniProtKB:P04156}.
METAL 81 81 Copper or zinc 3; via amide nitrogen.
{ECO:0000250|UniProtKB:P04156}.
METAL 82 82 Copper or zinc 3; via amide nitrogen and
carbonyl oxygen.
{ECO:0000250|UniProtKB:P04156}.
METAL 88 88 Copper or zinc 4.
{ECO:0000250|UniProtKB:P04156}.
METAL 90 90 Copper or zinc 4; via amide nitrogen.
{ECO:0000250|UniProtKB:P04156}.
METAL 91 91 Copper or zinc 4; via amide nitrogen and
carbonyl oxygen.
{ECO:0000250|UniProtKB:P04156}.
LIPID 233 233 GPI-anchor amidated alanine.
{ECO:0000255}.
CARBOHYD 184 184 N-linked (GlcNAc...) asparagine.
{ECO:0000305}.
CARBOHYD 200 200 N-linked (GlcNAc...) asparagine.
{ECO:0000305}.
DISULFID 182 217
VARIANT 112 112 M -> T. {ECO:0000269|PubMed:8094373}.
VARIANT 136 136 A -> V (in scrapie; short incubation; sA
allele). {ECO:0000269|PubMed:1681027,
ECO:0000269|PubMed:7897344,
ECO:0000269|PubMed:8094373}.
VARIANT 137 137 M -> T. {ECO:0000269|PubMed:8887505}.
VARIANT 141 141 L -> F. {ECO:0000269|PubMed:14769911,
ECO:0000269|PubMed:8887505,
ECO:0000269|Ref.8}.
VARIANT 154 154 R -> H. {ECO:0000269|PubMed:1681027,
ECO:0000269|PubMed:7897344,
ECO:0000269|PubMed:8094373}.
VARIANT 171 171 R -> H (in scrapie; low incidence).
{ECO:0000269|PubMed:7897344}.
VARIANT 171 171 R -> Q (linked to susceptibility to
scrapie). {ECO:0000269|PubMed:10466827,
ECO:0000269|PubMed:14769911,
ECO:0000269|PubMed:14970684,
ECO:0000269|PubMed:1681027,
ECO:0000269|PubMed:1969635,
ECO:0000269|PubMed:7926780,
ECO:0000269|PubMed:9799790,
ECO:0000269|Ref.8, ECO:0000269|Ref.9}.
VARIANT 211 211 R -> Q. {ECO:0000269|PubMed:8887505,
ECO:0000269|Ref.8}.
HELIX 112 114 {ECO:0000244|PDB:2N53}.
HELIX 123 126 {ECO:0000244|PDB:2N53}.
STRAND 128 130 {ECO:0000244|PDB:1XYU}.
STRAND 131 133 {ECO:0000244|PDB:1Y2S}.
TURN 144 146 {ECO:0000244|PDB:1S4T}.
HELIX 147 155 {ECO:0000244|PDB:1UW3}.
HELIX 157 159 {ECO:0000244|PDB:1UW3}.
STRAND 165 167 {ECO:0000244|PDB:1G04}.
HELIX 169 171 {ECO:0000244|PDB:1UW3}.
STRAND 173 175 {ECO:0000244|PDB:1UW3}.
HELIX 176 196 {ECO:0000244|PDB:1UW3}.
HELIX 203 229 {ECO:0000244|PDB:1UW3}.
SEQUENCE 256 AA; 27915 MW; 7FFBEA6C6FDBF8BB CRC64;
MVKSHIGSWI LVLFVAMWSD VGLCKKRPKP GGGWNTGGSR YPGQGSPGGN RYPPQGGGGW
GQPHGGGWGQ PHGGGWGQPH GGGWGQPHGG GGWGQGGSHS QWNKPSKPKT NMKHVAGAAA
AGAVVGGLGG YMLGSAMSRP LIHFGNDYED RYYRENMYRY PNQVYYRPVD RYSNQNNFVH
DCVNITVKQH TVTTTTKGEN FTETDIKIME RVVEQMCITQ YQRESQAYYQ RGASVILFSS
PPVILLISFL IFLIVG


Related products :

Catalog number Product name Quantity
20-783-74607 MOUSE ANTI PRION PROTEIN - PrP; Major scrapie-associated fibril protein 1; CD230 antigen Monoclonal 0.1 mg
11-593-C100 Mouse Monoclonal to CD230 _ Human Prion Protein (PrP) Antigen CD230 _ Human Prion Protein (PrP) Isotype IgG2a Antigen CD230 _ Human Prion Protein (PrP) Isotype IgG2a 0.1 mg
11-593-C025 Mouse Monoclonal to CD230 _ Human Prion Protein (PrP) Antigen CD230 _ Human Prion Protein (PrP) Isotype IgG2a Antigen CD230 _ Human Prion Protein (PrP) Isotype IgG2a 0.025 mg
A6-315-T100 Mouse Monoclonal to CD230 _ Human Prion Protein (PrP) Antigen CD230 _ Human Prion Protein (PrP) Species Reactivity Human Negative Species Clone MEM_238 Isotype IgG1 Application FC, WB Immunogen 100 tests
1A-315-T025 Mouse Monoclonal to CD230 _ Human Prion Protein (PrP) Antigen CD230 _ Human Prion Protein (PrP) Species Reactivity Human Negative Species Clone MEM_238 Isotype IgG1 Application FC, WB Immunogen 25 tests
C164 Recombinant Human Major Prion Protein per PRP per CD230 10ug
20-272-190924 Prion protein PrP - Mouse monoclonal [WD3C7] to Prion protein PrP; PrP; PrP27-30; PrP33-35C; ASCR; CD230 antigen Monoclonal 0.1 mg
20-272-191016 Prion protein PrP - Mouse monoclonal [7D9] to Prion protein PrP; PrP; PrP27-30; PrP33-35C; ASCR; CD230 antigen Monoclonal 0.1 ml
18-272-196859 Prion protein PrP - Rabbit polyclonal to Prion protein PrP; PrP; PrP27-30; PrP33-35C; ASCR; CD230 antigen Polyclonal 0.05 ml
18-783-76347 GOAT ANTI HUMAN PRION PROTEIN (CD230) - PRION PROTEIN; Polyclonal 0.01 ml
18-783-76346 GOAT ANTI HUMAN PRION PROTEIN (CD230) - PRION PROTEIN; Polyclonal 0.1 ml
EIAAB32380 Bos taurus,Bovine,Major prion protein,Major scrapie-associated fibril protein 1,PRNP,PrP,PRP
11-593-C100 CD230 _ Human Prion Protein (PrP) 0.1 mg
11-593-C025 CD230 _ Human Prion Protein (PrP) 0.025 mg
YSRTAHP498T CD230, Prion Protein, Goat anti_Human 0.02 ml.
YSRTAHP498 CD230, Prion Protein, Goat anti_Human 0.1 ml.
11-593-C025 Mouse Monoclonal to CD230 Human Prion Protein (PrP) 0.025 mg
bs-11788R Rabbit Anti-Prion protein PrP-CD230 Polyclonal Antibody 100ul
bs-11788R-Cy7 Rabbit Anti-Prion protein PrP-CD230 Polyclonal Antibody, Cy7 Conjugated 100ul
bs-11788R-Cy5 Rabbit Anti-Prion protein PrP-CD230 Polyclonal Antibody, Cy5 Conjugated 100ul
bs-11788R-Cy5.5 Rabbit Anti-Prion protein PrP-CD230 Polyclonal Antibody, Cy5.5 Conjugated 100ul
bs-11788R-A594 Prion protein PrP per CD230 Antibody, ALEXA FLUOR 594 Conjugated 100ul
bs-11788R-Cy3 Rabbit Anti-Prion protein PrP-CD230 Polyclonal Antibody, Cy3 Conjugated 100ul
11-593-C025 Mouse Monoclonal to CD230 Human Prion Protein (PrP), Clone EM-20, Isotype IgG2aApplication WB Concentration 1 mg ml 0.025 mg
11-593-C100 Mouse Monoclonal to CD230 Human Prion Protein (PrP), Clone EM-20, Isotype IgG2aApplication WB Concentration 1 mg ml 0.1 mg

Kits Elisa; taq POLYMERASE

Search in Google:

google

Share this page:
share on twitter rss feedsfacebookgoogle gentaur



Quick order!
Enter catalog number :


Gentaur; yes we can

Pathways :
WP1049: G Protein Signaling Pathways
WP1165: G Protein Signaling Pathways
WP1371: G Protein Signaling Pathways
WP1424: Globo Sphingolipid Metabolism
WP1438: Influenza A virus infection
WP1493: Carbon assimilation C4 pathway
WP1502: Mitochondrial biogenesis
WP1531: Vitamin D synthesis
WP1566: Citrate cycle (TCA cycle)
WP1613: 1,4-Dichlorobenzene degradation
WP1616: ABC transporters
WP1624: Bacterial secretion system
WP1625: Base excision repair
WP1644: DNA replication
WP1650: Fluorobenzoate degradation
WP1654: gamma-Hexachlorocyclohexane degradation
WP1657: Glycerolipid metabolism
WP1659: Glycine, serine and threonine metabolism
WP1661: Glyoxylate and dicarboxylate metabolism
WP1663: Homologous recombination
WP1665: Limonene and pinene degradation
WP1672: Mismatch repair
WP1673: Naphthalene and anthracene degradation
WP1675: Nitrogen metabolism
WP1676: Non-homologous end-joining

Related Genes :
[PRNP PRP] Major prion protein (PrP) (Major scrapie-associated fibril protein 1) (CD antigen CD230)
[PRNP ALTPRP PRIP PRP] Major prion protein (PrP) (ASCR) (PrP27-30) (PrP33-35C) (CD antigen CD230)
[Prnp Prn-p Prp] Major prion protein (PrP) (PrP27-30) (PrP33-35C) (CD antigen CD230)
[PRNP PRP] Major prion protein (PrP) (PrP27-30) (PrP33-35C) (CD antigen CD230)
[PRNP PRP] Major prion protein (PrP) (PrP27-30) (PrP33-35C) (CD antigen CD230)
[PRNP PRP] Major prion protein (PrP) (PrP27-30) (PrP33-35C) (CD antigen CD230)
[PRNP PRP] Major prion protein (PrP) (PrP27-30) (PrP33-35C) (CD antigen CD230)
[PRNP PRP] Major prion protein (PrP) (PrP27-30) (PrP33-35C) (CD antigen CD230)
[PRNP PRP QflA-10237] Major prion protein (PrP) (PrP27-30) (PrP33-35C) (CD antigen CD230)
[PRNP PRP] Major prion protein (PrP) (PrP27-30) (PrP33-35C) (CD antigen CD230)
[PRNP PRP SIP] Major prion protein (PrP) (CD antigen CD230)
[PRNP PRP] Major prion protein (PrP) (CD antigen CD230)
[Prnp Prn Prp] Major prion protein (PrP) (CD antigen CD230)
[PRNP PRP] Major prion protein (PrP) (CD antigen CD230)
[PRNP PRP] Major prion protein (PrP) (CD antigen CD230)
[PRNP PRP] Major prion protein (PrP) (CD antigen CD230)
[PRNP PRP] Major prion protein (PrP) (Major scrapie-associated fibril protein 1) (CD antigen CD230)
[PRNP PRP] Major prion protein (PrP) (PrP27-30) (PrP33-35C) (CD antigen CD230)
[PRNP PRP] Major prion protein (PrP) (PrP27-30) (PrP33-35C) (CD antigen CD230)
[PRNP PRP] Major prion protein (PrP) (PrP27-30) (PrP33-35C) (CD antigen CD230)
[PRNP PRP] Major prion protein (PrP) (PrP27-30) (PrP33-35C) (CD antigen CD230)
[PRNP PRP] Major prion protein (PrP) (PrP27-30) (PrP33-35C) (CD antigen CD230)
[PRNP PRP] Major prion protein (PrP) (PrP27-30) (PrP33-35C) (CD antigen CD230)
[PRNP PRP] Major prion protein (PrP) (PrP27-30) (PrP33-35C) (CD antigen CD230)
[PRNP PRP] Major prion protein (PrP) (PrP27-30) (PrP33-35C) (CD antigen CD230) (Fragment)
[PRNP PRP] Major prion protein (PrP) (PrP27-30) (PrP33-35C) (CD antigen CD230)
[PRNP PRP] Major prion protein (PrP) (PrP27-30) (PrP33-35C) (CD antigen CD230)
[PRNP PRP] Major prion protein (PrP) (PrP27-30) (PrP33-35C) (CD antigen CD230) (Fragment)
[PRNP PRP] Major prion protein (PrP) (PrP27-30) (PrP33-35C) (CD antigen CD230)
[PRNP PRP] Major prion protein (PrP) (PrP27-30) (PrP33-35C) (CD antigen CD230)

Bibliography :
[22076653] Functional mechanisms of the cellular prion protein (PrP(C)) associated anti-HIV-1 properties.
?>